Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins
Clinical trial NCT04478721 · COMPLETED
Trial details
- NCT number
- NCT04478721
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2024-12-26
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.